MetLife Investment Management’s Third Harmonic Bio THRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $91.5K | Buy |
+16,859
| New | +$91.5K | ﹤0.01% | 2593 |
|
|
2025
Q1 | – | Sell |
-12,859
| Closed | -$132K | – | 2824 |
|
|
2024
Q4 | $132K | Hold |
12,859
| – | – | ﹤0.01% | 2499 |
|
|
2024
Q3 | $174K | Hold |
12,859
| – | – | ﹤0.01% | 2357 |
|
|
2024
Q2 | $167K | Buy |
12,859
+1,255
| +11% | +$16.3K | ﹤0.01% | 2355 |
|
|
2024
Q1 | $110K | Hold |
11,604
| – | – | ﹤0.01% | 2490 |
|
|
2023
Q4 | $127K | Hold |
11,604
| – | – | ﹤0.01% | 2487 |
|
|
2023
Q3 | $74.2K | Buy |
+11,604
| New | +$74.2K | ﹤0.01% | 2734 |
|